Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04096209
Other study ID # CairoUimplant 2
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 30, 2019
Est. completion date June 2020

Study information

Verified date September 2019
Source Cairo University
Contact Sherine Osama El-Ebiary, BDS
Phone 01285594066
Email sherine.ebiary@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Xenografts are graft materials derived from the inorganic portion of animal bones; the most common source is bovine the removal of the organic component are processed to remove their antigenicity, while the remaining inorganic components provide a natural matrix as well as an excellent source of calcium. The disadvantage of xenografts is that they are only osteoconductive and the resorption rate of bovine cortical bone is slow.

However leaving the jumping gap empty has been the gold standard for immediate implantation as the formed blood clot will allow bone fill in that area.


Description:

Not using a grafting material in the jumping gap was chosen as a comparator as it's the standard procedure usually applied and showed high success rates. This should allow us to assess whether the chosen grafting material would have a positive influence on the study outcomes as compared to it.

Intraoral and extraoral autologous bone grafts could be considered as the "Gold standard" pre-prosthetic dentoalveolar reconstruction of atrophic jaws with cortico-cancellous bone grafts from intraoral and/or extraoral donor sites as a predictable technique for the facilitation of dental rehabilitation of atrophic ridges, associated with high bone survival rate and long term implant success. Autogenous bone corresponds to bone graft obtained from the same individual. It is considered the gold standard for filling of bone defects since it allows (I) osseointegration: direct contact with bone tissue without fibrous tissue ; (II) osteoconduction: support to bone growth (III) osteoinduction: differentiation of mesenchymal cells of surrounding tissue (receptor site) into osteoblastic cells ; and (IV) osteogenesis: bone neoformation by osteoblastic cells present in the graft material. Although few mature osteoblasts survive to grafting, precursor cells are responsible for the osteogenic potential


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 26
Est. completion date June 2020
Est. primary completion date June 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria:

- Age from 20-60 years

- Both sexes

- non-restorable maxillary incisors, canine and premolars

- Good oral hygiene

- Adequate bone height apical to the alveolus of the failing tooth

Exclusion Criteria:

- Systematic disease which affect osseointegration (uncontrolled diabetes, cancer, etc...)

- Bad oral hygiene

- Bruxism, clenching, deep bite, edge to edge and abnormal habits

- Non-treated periodontal diseases

- Pregnancy and smokers

- Severe infection

- Absence of labial plate of bone (Fenestration, dehiscence).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
autograft mixed with xenograft bone
Eligible patients will be randomized in equal proportions between control group (immediate implant placement without bone grafts in the jumping gap) and study group (immediate implant placement with a mixture of Xenograft and autogenous bone placed in the jumping gap). All patients will be evaluated by proper history taking and thorough clinical and radio graphical examination and assessed according to the inclusion and exclusion criteria. Patients of both groups will be subjected to Cone beam Computed tomography (CBCT). Primary impression will be taken, a study model will then be poured and then waxing up will be performed. Patients will be instructed to rinse with chlorhexidine 0.1% mouthwash. Articaine 4% (1:100,000) local anesthesia will be given to the patient. Atraumatic extraction of the tooth or remaining root using No. 15c lancet and periotome

Locations

Country Name City State
Egypt Cairo University Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Implant stability implant stability will be measured using osstell 4-6 months
See also
  Status Clinical Trial Phase
Recruiting NCT04738513 - One Year Clinical Evaluation of New Gradient Technology Monolithic Zirconia (5Y-TZP/3Y-TZP) Crowns in Dental Esthetic Zone With Vertical Versus Conventional Preparation Techniques N/A